| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |